These findings advance our understanding of <i>H.</i> <i>pylori</i>-mediated disease and identify gastric IL-37 as a therapeutic target to combat <i>H.</i> <i>pylori</i> infection and associated diseases. This evidence concerns the gene IL37 and infection.